The Newsroom of Cholangiocarcinoma Foundation

Cholangiocarcinoma Foundation Press Releases

  • Published on November 10, 2016 - 13:41 GMT

    Saha Laboratory Opens Doors to Study Highly Lethal Cancer of the Bile Ducts

    Cholangiocarcinoma Foundation Sees Great Promise in New Research Lab SALT LAKE CITY, UTAH, USA, November 9, 2016 /EINPresswire.com/ -- With the opening of the Saha Laboratory for Liver Cancer Translational Research, a giant step forward has been made in the study of cholangiocarcinoma, a highly lethal malignancy of the liver bile ducts. Supryia Saha, MD PhD, has joined world-class scientists in Seattle at the Fred Hutch Cancer Research Center - the home of three Nobel laureates - to revolutionize …

    Distribution channels: Business & Economy, Education ...
  • Published on September 28, 2016 - 10:00 GMT

    Award-winning Retailer Teams-up with the Cholangiocarcinoma Foundation to Support Research

    Charming Charlie’s Charitable Giving Program Raises Awareness and Funds SALT LAKE CITY, UTAH, UNITED STATES, September 27, 2016 /EINPresswire.com/ -- Charming Charlie, a women’s fashion and accessories retailer with more than 370 locations worldwide supports non-profit organizations through their in-store fundraising events. During 'Charming Charlie Cares' events, ten percent of all purchases are donated to the hosting charity. On September 17th, the Charming Charlie store in Happy Valley, …

    Distribution channels: Beauty & Hair Care, Business & Economy ...
  • Published on September 16, 2016 - 20:02 GMT

    Scientists Investigate Improved Treatments and a Cure for Rare Disease – Bile Duct Cancer

    Now Accepting Applications for the Cholangiocarcinoma Foundation Research Fellowship Program SALT LAKE CITY, UTAH, UNITED STATES, September 16, 2016 /EINPresswire.com/ -- The Cholangiocarcinoma Foundation (CCF), a nonprofit organization funding novel research for bile duct cancer is now accepting applications for the 3rd cycle of its Research Fellowship Program. Since 2015, the Foundation has awarded 4 grants totaling $200,000 to outstanding scientists to raise awareness about cholangiocarcinoma and …

    Distribution channels: Conferences & Trade Fairs, Education ...
  • Published on September 13, 2016 - 21:56 GMT

    Charlie Chanaratsopon, CEO and Founder of “Charming Charlie” Cares

    The abbreviation for cholangiocarcinoma, a rare form of liver cancer is “CC” however, one “CC” patient in Oregon prefers to think of it as “Charming Charlie.” SALT LAKE CITY, UTAH, UNITED STATES, September 13, 2016 /EINPresswire.com/ -- Lisa Layton has a diagnosis of stage IV intrahepatic cholangiocarcinoma. She was first introduced to the brand “Charming Charlie” while a patient at Oregon Health Sciences University in Portland, Oregon. While undergoing treatment in the oncology unit, Lisa received a …